Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Sorting through the Details of an Automation Solution - Insights
Laboratories face increasing pressure to automate their operations as they are challenged by a continuing increase in workload, a need to reduce expenditure, and a demand for accuracy and improved turnaround time—essentially doing more with...
QuantiFERON-TB Gold Plus - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.
JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified,...
Each day, some 40 to 45 thousand specimens are shipped to Mayo Clinic Laboratories in Rochester, Minnesota, from hospitals and other health care organizations around the world. And for every sample, there’s a patient to whom it belongs,...
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights
In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...